Polycystic kidney disease surgery

Jump to: navigation, search

Polycystic kidney disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic kidney disease from other Diseases

Epidemiology and Demographics

Risk Factor

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polycystic kidney disease surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic kidney disease surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic kidney disease surgery

CDC on Polycystic kidney disease surgery

Polycystic kidney disease surgery in the news

Blogs on Polycystic kidney disease surgery

Directions to Hospitals Treating Polycystic kidney disease

Risk calculators and risk factors for Polycystic kidney disease surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either end stage renal disease (ESRD), recurrent UTI, chronic pain, renal cell carcinoma, chronic hematuria requiring transfusions. Surgical options are either nephrectomy or renal transplantation.

Indications

Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either:[1][2][3]

Surgery

Contraindications

References

  1. Hadimeri H, Nordén G, Friman S, Nyberg G (July 1997). "Autosomal dominant polycystic kidney disease in a kidney transplant population". Nephrol. Dial. Transplant. 12 (7): 1431–6. PMID 9249781.
  2. Glassman DT, Nipkow L, Bartlett ST, Jacobs SC (September 2000). "Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease". J. Urol. 164 (3 Pt 1): 661–4. PMID 10953121.
  3. Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE (December 2005). "End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation". J. Urol. 174 (6): 2284–8. doi:10.1097/01.ju.0000181208.06507.aa. PMID 16280813.
  4. Torres VE, Harris PC (July 2009). "Autosomal dominant polycystic kidney disease: the last 3 years". Kidney Int. 76 (2): 149–68. doi:10.1038/ki.2009.128. PMC 2812475. PMID 19455193.
  5. Ring T, Spiegelhalter D (December 2007). "Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease". Kidney Int. 72 (11): 1400–2. doi:10.1038/sj.ki.5002488. PMID 17882153.

Linked-in.jpg